| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1034/J.1399-3062.1999.010402.X |
| P698 | PubMed publication ID | 11428994 |
| P2093 | author name string | Patterson JE | |
| P2860 | cites work | Systemic availability of itraconazole in lung transplantation | Q24675285 |
| CNS aspergillosis in organ transplantation: a clinicopathological study | Q33590600 | ||
| Infections due to dematiaceous fungi in organ transplant recipients: case report and review | Q34422669 | ||
| Infection in organ-transplant recipients | Q34471508 | ||
| Brain abscess in solid organ transplant recipients receiving cyclosporine-based immunosuppression | Q34480412 | ||
| Fungal infections in liver transplant recipients | Q34561594 | ||
| Evaluation of pulsed-field gel electrophoresis as a typing system for Candida rugosa: comparison of karyotype and restriction fragment length polymorphisms | Q40010901 | ||
| Epidemiology of nosocomial fungal infections, with emphasis on Candida species | Q40405962 | ||
| Fungal infections in solid-organ transplantation | Q40914902 | ||
| Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission | Q41044976 | ||
| Fungal infections in lung and heart-lung transplant recipients. Report of 9 cases and review of the literature. | Q41269382 | ||
| Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole | Q43543160 | ||
| Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis | Q43603281 | ||
| Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients | Q43802277 | ||
| Intracranial infection in cardiac transplant recipients | Q44183285 | ||
| Clinical spectrum of fungal infections after orthotopic liver transplantation | Q44572653 | ||
| Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit | Q46390977 | ||
| Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. | Q51194161 | ||
| Risk factors for invasive fungal infections complicating orthotopic liver transplantation. | Q51195234 | ||
| Infection in the renal transplant recipient. | Q51198330 | ||
| Intra-abdominal infections in pancreas transplant recipients. | Q54148187 | ||
| Pancreas transplantation at Mayo: III. Multidisciplinary management | Q68769293 | ||
| Risk factors for hospital-acquired candidemia. A matched case-control study | Q69771679 | ||
| Infectious complications in heart-lung transplant recipients | Q70103541 | ||
| Nosocomial acquisition of Candida parapsilosis: an epidemiologic study | Q70458786 | ||
| Aspergillus infection in single and double lung transplant recipients | Q71062292 | ||
| Nosocomial candidemia: risk factors and attributable mortality | Q71716576 | ||
| Infections in solid-organ transplant recipients | Q73818592 | ||
| National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units | Q78221560 | ||
| The epidemiology of pseudallescheriasis complicating transplantation: Nosocomial and community-acquired infection | Q89704243 | ||
| P433 | issue | 4 | |
| P921 | main subject | epidemiology | Q133805 |
| patient | Q181600 | ||
| P304 | page(s) | 229-236 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | Transplant Infectious Disease | Q15749562 |
| P1476 | title | Epidemiology of fungal infections in solid organ transplant patients | |
| P478 | volume | 1 |
| Q37583674 | A study on Aspergillus species in houses of asthmatic patients from Sari City, Iran and a brief review of the health effects of exposure to indoor Aspergillus |
| Q42266965 | A woman with a painful eruption following liver transplantation |
| Q38688900 | Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection |
| Q45304657 | Aspergillus thyroiditis in a renal transplant recipient mimicking subacute thyroiditis |
| Q41874538 | Candida albicans Mds3p, a conserved regulator of pH responses and virulence identified through insertional mutagenesis. |
| Q36359387 | Candida dubliniensis bloodstream infection: a fatal case in a lung transplant recipient. |
| Q42272295 | Candida infections in solid organ transplantation |
| Q44267733 | Candidemia following solid organ transplantation in the era of antifungal prophylaxis: the Australian experience |
| Q37624699 | Clinical aspects of invasive candidiasis in the surgical patient |
| Q33628293 | Cytomegalovirus and Aspergillus spp. coinfection in organ transplantation: a case report and review of the literature |
| Q37900310 | Diagnosing invasive fungal disease in critically ill patients |
| Q37650317 | Diagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients. |
| Q54511639 | Disseminated Cryptococcus neoformans var. grubii infections in intensive care units. |
| Q43849891 | Disseminated candidiasis developing during prophylaxis with fluconazole in a small-intestine transplant recipient |
| Q40321055 | Endemic and opportunistic infections in Brazilian solid organ transplant recipients. |
| Q36876327 | Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience. |
| Q34490092 | Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? |
| Q37114436 | Fusarium infection in lung transplant patients: report of 6 cases and review of the literature |
| Q35599856 | Glucocorticoids and invasive fungal infections |
| Q35986578 | Impact of abdominal drainage systems on postoperative complication rates following liver transplantation |
| Q80783433 | Incidence of fungal infections in a solid organ recipients dedicated intensive care unit |
| Q39290452 | Invasive Fungal Disease in Renal Transplant Recipients at a Brazilian Center: Local Epidemiology Matters. |
| Q36895540 | Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients |
| Q36872848 | Invasive fungal infections and antifungal therapies in solid organ transplant recipients. |
| Q36884359 | Invasive pulmonary aspergillosis due to Emericella nidulans var. echinulata, successfully cured by voriconazole and micafungin |
| Q58075905 | Iron: an essential nutrient for Aspergillus fumigatus and a fulcrum for pathogenesis |
| Q46598209 | Lymphocutaneous nocardiosis and cutaneous pheohyphomycosis in a liver transplant recipient |
| Q37909774 | Management of fungal lung disease in the immunocompromised. |
| Q35841369 | Management of opportunistic infections in solid-organ transplantation |
| Q54269213 | Microhemorrhage-associated tissue iron enhances the risk for Aspergillus fumigatus invasion in a mouse model of airway transplantation. |
| Q46064554 | Mucosal Candida infection and colonisation as well as associated risk factors in solid organ transplant recipients |
| Q37235612 | Oral Candida infection and colonization in solid organ transplant recipients |
| Q36891164 | Oral candidiasis in patients with renal transplants |
| Q37263189 | Patients at high risk of invasive fungal infections: when and how to treat |
| Q28828197 | Phaeoacremonium parasiticum myositis: A case report with imaging findings |
| Q37389541 | Pinpointing prognostic indicators of fungal infections in transplant patients |
| Q38237895 | Posaconazole salvage treatment for invasive fungal infection |
| Q45323330 | Pulmonary fungal infections in kidney transplant recipients: an 8-year study |
| Q34042068 | Rapid identification of Candida species and other clinically important yeast species by flow cytometry |
| Q35240401 | Risk factors for invasive fungal disease in heart transplant recipients. |
| Q44800864 | Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis |
| Q42286809 | Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients. |
| Q38035717 | State of the art diagnostic of mold diseases: a practical guide for clinicians |
| Q44842818 | The economic costs to United States hospitals of invasive fungal infections in transplant patients |
| Q42205282 | Therapeutic approach to respiratory infections in lung transplantation |
| Q36328703 | Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections |
| Q44417870 | Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections |
Search more.